—
Market InsightsCannabionoids are natural extracts derived from Cannabis sativa, Cannabis indica and Cannabis ruderalis. For times marijuana has been used widely for recreational, medical and ritualistic purposes. It covers of psychoactive drug component tetrahydrocannabinol which causes the stimulation of the cannabinoid receptor CB1 and CB2 respectively. The activation of these receptors results in pain relieving activity in patients suffering with chronic pain due to AIDS, cancer, neuropathic pain etc., In the last decade marijuana has been a keen research subject for researchers and academicians throughout the globe to understand its therapeutic advantages in treating anorexia and nausea. Positive steps have been taken by healthcare and law enforcing agencies to legalize the production and sale of marijuana for medicinal purpose. Tremendous focus is laid in drafting guidelines for the judicious use of marijuana in healthcare centers. Nowadays marijuana is available as weed infused gums, tampons, cannabinoid infused tea, bath salts, cannabinoid infused coffee and topical balms to get relief from pain.
Browse the full report Medical Marijuana Market - Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/medical-marijuana-market
Rising prevalence of patients suffering with cancer to drive the medical marijuana market
Supportive regulatory environment and government approval to propel the sale of medical marijuana in hospital pharmacies
Rise in chronic pain and cancer in geriatric population to drive the medical marijuana market growth in North America
North America currently dominates the medical marijuana market with 52% share. The growing prevalence of geriatric patients suffering from chronic pain and growing number of patients suffering from cancer drive the medical marijuana market in North America. U.S. Food and Drug Administration (USFDA) has been proactive in understanding the medicinal requirement of marijuana in treating anorexia, and nausea by giving fast-track drug approval. In Europe, the approval of marijuana for medicinal purposes faces tremendous challenges as there is no unison among the local regulatory agencies. Since 2016, Germany has drafted regulatory guidelines for the production and sale of marijuana for medicinal purposes. Other European Union countries have started working on the same statutes adopted by Germany for growth of medical marijuana market in European Union. Rest of the world will be the fastest growing regional segment for the medical marijuana market on account of key factors largest production of legal marijuana (Cannabis sativa and Cannabis indica) in countries such as Afghanistan, Australia and South Asian countries. Rest of the world holds three fourths of the patients suffering with chronic pain and cancer. Regulatory agencies are working to legalize the sale of marijuana in hospital pharmacies and dispensaries for medicinal purposes.
Report Scope by Segments
Marker estimation and compounded annual growth rate for the report medical marijuana market was determined by quantitative analysis. The market segmentation consists of application, point of sale and geography.
By Application (2016–2026; US$ Mn)
• Chronic Pain
• Neurological Disorders
• Cancer
• Others (Anorexia, Nausea etc.)
• By Point of Sale (2016–2026; US$ Mn)
• Online Pharmacy
• Dispensaries
ToC:
Chapter 4. Global Medical Marijuana Market, by Application
4.1. Overview
4.2. Chronic Pain
4.3. Neurological Disorders
4.4. Cancer
4.5. Others (Anorexia, Nausea etc.)
Chapter 5. Global Medical Marijuana Market, by Point of Sale
5.1. Overview
5.2. Hospital Pharmacy
5.3. Dispensaries
Chapter 6. Global Medical Marijuana Market, by Geography
6.1. Overview
6.2. North America Medical Marijuana Market Analysis, 2016 – 2026
6.2.1. North America Medical Marijuana Market, by Application, 2016 – 2026 (US$ Mn)
6.2.2. North America Medical Marijuana Market, by Point Of Sale, 2016 – 2026 (US$ Mn)
6.2.3. North America Medical Marijuana Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Medical Marijuana Market Analysis, 2016 – 2026
6.3.1. Europe Medical Marijuana Market, by Application, 2016 – 2026 (US$ Mn)
6.3.2. Europe Medical Marijuana Market, by Point Of Sale, 2016 – 2026 (US$ Mn)
6.3.3. Europe Medical Marijuana Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Latin America Medical Marijuana Market Analysis, 2016 – 2026
6.4.1. Latin America Medical Marijuana Market, by Application, 2016 – 2026 (US$ Mn)
6.4.2. Latin America Medical Marijuana Market, by Point Of Sale, 2016 – 2026 (US$ Mn)
6.4.3. Latin America Medical Marijuana Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. Brazil
6.4.3.2. Mexico
6.4.3.3. Rest of Latin America
6.5. Rest of World Medical Marijuana Market Analysis, 2016 – 2026
6.5.1. RoW Medical Marijuana Market, by Application, 2016 – 2026 (US$ Mn)
6.5.2. RoW Medical Marijuana Market, by Point Of Sale, 2016 – 2026 (US$ Mn)
6.5.3. RoW Medical Marijuana Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Australia
6.5.3.2. Israel
6.5.3.3. Rest of World
Chapter 7. Company Profiles
7.1. AbbVie, Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. CannaGrow Holdings, Inc.
7.3. Canopy Growth Corporation, Inc.
7.4. GW Pharmaceuticals, Plc.
7.5. Insys Therapeutics, Inc.
7.6. Novartis AG
7.7. Lexaria Corporation
7.8. Pfizer, Inc.
7.9. Teva Pharmaceutical Industries Ltd.
7.10. United Cannabis Corporation
Browse the full report Medical Marijuana Market - Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/medical-marijuana-market
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE,, CA 95103, United States
Phone: 18003618290
Website: https://www.credenceresearch.com/report/medical-marijuana-market
Release ID: 459199
Google
RSS